project id: TCGA-THCA; case submitter id: TCGA-DE-A3KN; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.0; age at index: 49; days to birth: -18098; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18098; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 831.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 183; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-DE-A3KN-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 100.0;